Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Nov;141(5):1115-24.

Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice

Affiliations

Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice

R D Zhang et al. Am J Pathol. 1992 Nov.

Abstract

This study clarified whether and when the blood-brain barrier in experimental brain metastases is impaired by using hydrosoluble sodium fluorescein (MW 376) as a blood-brain barrier function indicator. Cells from eight human tumor lines (four melanomas, two breast carcinomas, one colon carcinoma, and one renal carcinoma) were inoculated into the internal carotid artery of nude mice. Brain metastases at different stages of development were sampled and the permeability of the blood-brain barrier around the metastases determined. Histologic examination showed two patterns of tumor growth. In the first, tumor cells formed isolated, well-defined nodules in the parenchyma of the brain. In lesions smaller than 0.2 mm2, the blood-brain barrier was intact. In the second, small diffuse nests of tumor cells were distributed throughout the brain parenchyma. The blood-brain barrier was intact until the small tumor cell colonies coalesced to form large tumor masses. These results suggest that the permeability of the blood-brain barrier varies among different experimental brain metastases and that its function is related to the growth pattern and size of the lesions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Chemother Pharmacol. 1990;27(1):1-7 - PubMed
    1. J Neuropathol Exp Neurol. 1990 Sep;49(5):486-97 - PubMed
    1. Int J Microcirc Clin Exp. 1990 Nov;9(4):369-83 - PubMed
    1. Am J Pathol. 1990 Jan;136(1):95-102 - PubMed
    1. Cancer Chemother Pharmacol. 1990;26(4):263-8 - PubMed

Publication types